Procainamide: Clinical Pharmacology and Efficacy against Ventricular Arrhythmias (Q40075865)

17 September 2017

1 reference

title

Procainamide: clinical pharmacology and efficacy against ventricular arrhythmias (English)

1 reference

17 September 2017

Procainamide: Clinical Pharmacology and Efficacy against Ventricular Arrhythmias (English)

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

history and philosophy of science

1 August 2023

main subject

procainamide

0 references

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

1 August 2023

author name string

E. G. Giardina

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6084435

1 August 2023

language of work or name

English

0 references

publication date

1 January 1984

1 reference

full work available at URL

17 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1984.tb14519.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1984.tb14519.x/fullpdf

1 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Annals of the New York Academy of Sciences

1 August 2023

published in

1 reference

17 September 2017

volume

432

1 reference

17 September 2017

page(s)

177-188

1 reference

Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. B

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Procaine amide against re-entrant ventricular arrhythmias. Lengthening R-V intervals of coupled ventricular premature depolarization as an insight into the mechanism of action of procaine amide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

The use of procaine amide in cardiac arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

21 January 2018

Procaine amide; a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

A study of the effect of procaine amide hydrochloride in supraventricular arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Metabolism of procainamide in normal and cardiac subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Pharmacokinetics of procainamide intravenously and orally as conventional and slow-release tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Efficacy, plasma concentrations and adverse effects of a new sustained release procainamide preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Intracardiac electrophysiologic studies as a method for the optimization of drug therapy in chronic ventricular arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Long-term use of procaine amide following acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Antiarrhythmic Drug Therapy for Sporadic Ventricular Ectopic Arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Antiarrhythmic drug effect mimicked by spontaneous variability of ventricular ectopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Plasma levels of procaine amide after administration of conventional and sustained-release tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Pharmacokinetics in man of theN-acetylated metabolite of proeainamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Dose-ranging trial of N-acetylprocainamide in patients with premature ventricular contractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Reversible lupus-like illness induced by procainamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Polymorphic acetylation of procainamide in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainamide and quinidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: Comparison with procainamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1984.TB14519.X

Electrophysiologic effects of procainamide on sinus function in patients with and without sinus node disease

21 January 2018

5

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure

1 August 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics

1 August 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Oral flecainide acetate for the treatment of ventricular arrhythmias

1 August 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Procainamide dosage schedules, plasma concentrations, and clinical effects

1 August 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Antiarrhythmic Prophylaxis with Procainamide in Acute Myocardial Infarction

1 August 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Large dose procainamide therapy for ventricular tachyarrhythmia

1 August 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Procainamide and phenytoin. Comparative study of their antiarrhythmic effects at apparent therapeutic plasma levels

1 August 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency

1 August 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Antiarrhythmic efficacy of encainide and quinidine: validation of a model for drug assessment

1 August 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes

1 August 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia

1 August 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

The effect of quinidine and other oral antiarrhythmic drugs on serum digoxin. A prospective study

1 August 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide

1 August 2023

35

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Long-term antiarrhythmic therapy with acetylprocainamide

1 August 2023

36

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

A reversal of the cardiotoxic effects of procaine amide by molar sodium lactate

1 August 2023

37

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Procainamide-induced lupus erythematosus

1 August 2023

38

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

The relationship between the metabolism of procainamide and sulfamethazine

1 August 2023

40

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome

1 August 2023

42

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

1 August 2023

43

44

664

Alarcon-Segovia D.

1969

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1984.TB14519.X

1 August 2023

Identifiers

1 reference

17 September 2017

1 reference